Morishita Ryuichi | Department Cf Clinical Gene Therapy Graduate School Of Medicine Osaka University
スポンサーリンク
概要
- MORISHITA Ryuichiの詳細を見る
- 同名の論文著者
- Department Cf Clinical Gene Therapy Graduate School Of Medicine Osaka Universityの論文著者
関連著者
-
Morishita Ryuichi
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
OGIHARA Toshio
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
Aoki Motokuni
Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
KANEDA Yasufumi
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University
-
Aoki Motokuni
Department Of Geriatric Medicine
-
Aoki Motokuni
Department Of Geriatric Medicine Osaka University Medical School
-
MORISHITA Ryuichi
Department of Clinical Gene Therapy, Osaka University
-
Takami Yoichi
Department Of Geriatric Medicine And Nephrology Osaka University Graduate School Of Medicine
-
Nakahama Hajime
Division Of Hypertension And Nephrology National Cardiovascular Center
-
NAKAGAMI Hironori
Division of Gene Therapy Science, Osaka University Graduate School of Medicine
-
Aoki Motokuni
大阪大学 臨床遺伝子治療学
-
Morishita Ryuichi
東京大学 先端臨床医学開発講座
-
Nakagami Hironori
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
Niki Hisae
国立がんセンター中央病院 消化器内科
-
Azuma Junya
Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
Makino Hirofumi
Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
Tabara Yasuharu
国立循環器病センター研究所 疫学部
-
TANIYAMA Yoshiaki
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
HASHIYA Naotaka
Department of Geriatric Medicine, Osaka University Medical School
-
Tarutani Yasuhiro
Division Of Cardiology Department Of Medicine Kohka Public Hospital
-
RAKUGI Hiromi
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
Kawano Yuhei
国立循環器病センター 高血圧腎臓内科
-
TOMITA Naruya
Department of Geriatric Medicine, Osaka University Medical School
-
Miyata Toshiyuki
Research Institute National Cardiovascular Center
-
Tabara Yasuharu
西予市立野村病院 内科
-
Iekushi Kazuma
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Morisaki Takayuki
国立循環器病センター 心臓血管内科
-
KATSUYA Tomohiro
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita
-
Tsubakimoto Yoshinori
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Naritomi Hiroaki
Division Of Cardiology National Cardiovascular Center
-
Nakamura Toshikazu
Division Of Molecular Regenerative Medicine Graduate School Of Medicine Osaka University
-
Nonogi Hiroshi
Cardiology And Emergency Medicine National Cardiovascular Center
-
Rakugi Hiromi
東北大学 臨床薬学
-
Sanada Fumihiro
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
YAMASAKI Keita
Department of Geriatric Medicine, Osaka University Medical School
-
ISOBE Mitsuaki
Department of Cardiovascular Medicine, Tokyo Medical and Dental University
-
HIGAKI Jitsuo
Department of Integrated Medicine and Informatics, Ehime University Medical School
-
Nonogi Hiroshi
国立循環器病センター研究所 疫学部
-
Nonogi H
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
Tomita Naruya
Division of Nephrology, Department of Internal Medicine, Kawasaki Mediccal School
-
Nonogi Hiroshi
The Third Division Department Of Internal Medicine Kyoto University
-
Katsuya Tomohiro
Department Of Clinical Gene Therapy Osaka University Graduated School Of Medicine
-
MORIGUCHI Atsushi
Department of Geriatric Medicine, Osaka University Medical School
-
Nakahama Hajime
国立循環器病センター 高血圧腎臓内科
-
Kaneda Yasufumi
Division Of Gene Therapy Science Osaka University
-
Masuo Kazuko
Nucleus Network Ltd. Baker Idi Heart And Diabetes Institute
-
SATO Naoyuki
Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School o
-
Tomino Y
Department Of Basic Medical Research And Education Ehime University Graduate School Of Medicine
-
北 徹
Department Of Geriatric Medicine Osaka University Graduate School Of Medicine
-
KAWANO Yuhei
National Cardiovascular Center
-
Kosakai Yoshio
Department Of Cardiovascular Surgery National Cardiovascular Center
-
Tsubakihara Yoshiharu
Department Of Nephrology Osaka Prefectural Hospital
-
Dohsaka Norio
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Koibuchi Nobutaka
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Kawamura Tetsuya
東京慈恵会医科大学 腎臓･高血圧内科
-
SUZUKI Jun-ichi
Department of Advanced Clinical Science and Therapeutics, University of Tokyo
-
AIZAWA Yoshifusa
Division of Cardiology, Niigata University Graduate School of Medical and Dental Sciences
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
Tsutsumi Yoshiaki
国立循環器病センター
-
Tsujita Yasuyuki
Department Of Geriatric Medicine Osaka University Graduate School Of Medicine
-
Masuo Kazuko
Kagawa University
-
Tsubakimoto Yoshinori
Department Of Cardiolgy Kyoto Prefectural University Of Medicine
-
TSUKAMOTO Yusuke
Syuwa General Hospital
-
Morishita Ryuichi
Department Of Clinical Gene Therapy Osaka University
-
HAYASHI Takuya
Department of Investigative Radiology, National Cardiovascular Center Research Institute
-
Isobe Mitsuaki
Japanese Circulation Society Guideline Preparation Group Myocarditis
-
Morisaki Takayuki
Department Of Biosciences Research Institute National Cardiovascular Center
-
OHISHI Mitsuru
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
荻原 俊男
Division Of Preventive Cardiology National Cardiovascular Center
-
OGIHARA Toshio
Osaka University
-
KATSUYA Tomohiro
Osaka University
-
KOHNO Masakazu
Kagawa University
-
SHIMIZU Hideo
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
KUNUGIZA Yasuo
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
TOMITA Tetsuya
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
喜多 義邦
Division Of Preventive Cardiology National Cardiovascular Center
-
Kotani Yasushi
国立循環器病センター 予防検診
-
Koriyama Hiroshi
Department of Geriatric Medicine, Osaka University Medical School
-
Mori Masaki
Division of Gene Therapy Science, Osaka University Graduate School of Medicine
-
Hayashi Hiroki
Division of Gene Therapy Science, Osaka University Graduate School of Medicine
-
Morishita Ryuichi
Division of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Ohama Tohru
大阪大学 医学系研究科循環器内科学
-
Tochikubo Osamu
横浜市立大学 第2内科
-
Yokoi Toyohiko
Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University
-
Kusunoki Hiroshi
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Suzuki Jun-ichi
Department Of Advanced Clinical Science And Therapeutics University Of Tokyo
-
MATSUMOTO Kunio
Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University
-
Kaneda Yasufumi
Institute for Molecular and Cellular Biology, Osaka University Medical School
-
Tochikubo Osamu
Division Of Cardiology Yokohama City University Medical Center
-
Ohkubo Takayoshi
東北大学 臨床薬学
-
Ohkubo Takayoshi
The Department Of Public Health Tohoku University Graduate School Of Pharmaceutical Science And Medi
-
荻原 俊男
大阪大 大学院医学系研究科 生体制御医学専攻 加齢医学
-
Okura Takafumi
愛媛大学 医学系研究科病態情報内科学
-
Suzuki Jun-ichi
東京大学 先端臨床医学開発講座
-
Ohtsuka Tomoaki
愛媛大学 医学系研究科臨床看護学
-
Matsubara Mitsunobu
Department Of Medicine And Clinical Science Yamaguchi University Graduate School Of Medicine
-
Miyahara Mitsuo
The Second Department Of Internal Medicine Sapporo Medical College
-
Kobayashi Yoshio
Cardiovascular Division National Cardiovascular Center
-
ITO Hiroshi
Department of Internal Medicine, Division of Cardiovascular Medicine, Akita University Faculty of Me
-
Egashira Kensuke
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
Shimamoto Kazuaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
北 徹
京都大学大学院医学研究科循環器内科学
-
Hoshikawa Yoshiko
Div. Of Molecular And Genetic Medicine Dep. Of Genetic Medicine And Regenerative Therapeutics Gradua
-
Kita Toru
京都大学 医学研究科循環器内科学
-
OSAKO Mariana
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
AKASAKA Hiroshi
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
SAITOH Shigeyuki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Shimamoto K
Department Of Internal Medicine Ii Sapporo Medical University
-
Nakagami Hironori
Department Of Cardiovascular Medicine National Cardiovascular Center
-
Sata Masataka
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University
-
Yamada Hiroyuki
Ami-kyoto Multi-center Risk Study Group
-
Katsuya Tomohiro
東北大学 臨床薬学
-
NAKAMURA Toshikazu
Biomedical Research Center, Osaka University School of Medicine
-
Shimamoto Kazuaki
大阪大学 医学系研究科老年内科
-
azuma jyunya
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
Kokubo Yoshihiro
愛媛大学 医学系研究科医療環境情報解析学講座公衆衛生健康医学
-
Yokoi Hirokazu
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Nagai Ryouzou
Department Of Cardiovascular Medicine Graduate School Medicine University Of Tokyo
-
Morishita Ryuichi
the Department of Geriatric Medicine, Keio University School of Medicine
-
Ogihara Toshio
the Department of Geriatric Medicine, Keio University School of Medicine
-
Mochizuki Naoki
Department of Cardiology, National Cardiovascular Center
-
Ogihara Toshio
The Department Of Geriatric Medicine Osaka University Medical School
-
Saitoh Shigeyuki
Department Of Internal Medicine Ii Sapporo Medical University
-
Kawamura T
The Division Of Nephrology And Hypertension
-
Sugimoto Ken
東北大学 臨床薬学
-
Sugimoto Ken
Department Of Geriatric Medicine Osaka University Graduate School Of Medicine
-
Mochizuki Naoki
Department Of Structural Analysis National Cardiovascular Center Research Institute
-
Yasue H
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
Kita Toru
National Hospital Organization And Department Of Cardiovascular Medicine Graduate School Of Medicine
-
KIMURA Tokihisa
Furukawa City Hospital
-
Ogihara Toshio
Department Of Geriatric Medicine Osaka University Medical School
-
HORI Masatsugu
Osaka Medical Center for Cancer and Cardiovascular Disease
-
NAGAI Ryozo
Department of Cardiovascular Medicine, University of Tokyo
-
北 徹
京都大学老年科
-
Horiuchi Masatsugu
Department of Medical Biochemistry 1, Ehime University School of Medicine
-
Kita Toru
Department Of Cardiovascular Medicine Kobe City Medical Center General Hospital
-
Sakamoto Kazuhiko
Division Of Internal Medicine Saito Hospital
-
tabata yasuhiko
Department of Biomaterials, Institute for Frontier Medical Science, Kyoto university
-
SUGIMOTO Ken
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
NAKAGAMI Futoshi
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine
-
OGIHRARA Toshio
Osaka General Medical Center
-
Fujio Yasushi
Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical S
-
Morishita Ryuichi
Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine
-
Kamide Kei
国立循環器病センター 高血圧腎臓内科
-
FUJIWARA Yoshikazu
Department of Physics, Kyoto University
-
Komada Yoshihiro
三重大学 医学系研究科小児発達医学
-
Nagai Ryouzou
Department of Cardiovascular Medicine, The University of Tokyo
-
Yamashita Hidetoshi
Division of Gene Therapy Science, Osaka University Graduate School of Medicine
-
Maeda Shiro
Laboratory for Diabetic Nephropathy, SNP Research Center, The Institute of Physical and Chemical Res
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
Shimada Kazuyuki
大阪府立病院機構大阪府立急性期総合医療センター
-
Kita Toru
Department Of Geriatric Medicine Graduate School Of Medicine Kyoto University
-
Komuro Issei
Department of Cardiovascular Science and Medicine, Chiba University graduate School of Medicine
-
Shirato Kunio
山口大学 医学系研究科器官病態内科学
-
UCHIYAMA Yasuo
Department of Cell Biology and Neuroscience (A1), Osaka University Graduate School of Medicine
-
WAGURI Satoshi
Department of Anatomy and Histology, Fukushima Medical University, School of Medicine
-
Kohno Masakazu
香川大学 医学部循環器内科
-
Kaneko Yoshihiro
Second Department Of Internal Medicine Yokohama City University Hospital
-
Tsubakihara Yoshiharu
大阪府立病院機構大阪府立急性期総合医療センター 腎臓･高血圧内科
-
Shirato K
Department Of Internal Medicine Ii Sapporo Medical University
-
Nakamura Y
Human Genome Center Institute Of Medical Science University Of Tokyo
-
Isobe Mitsuaki
東京医科歯科大学 循環制御内科学
-
Iemitsu Motoyuki
Department Of Cardiovascular Medicine Tokyo Medical And Dental University
-
Kokubo Yoshihiro
国立循環器病センター研究所 疫学部
-
Nagai R
Department Of Cardiology The University Of Tokyo
-
Nagai Ryozo
武蔵野赤十字病院
-
Nagai Ryozo
東京大学 心臓外科学
-
Ohama Tohru
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
HIGASHI Yukihito
Department of Cardiovascular Physiology and Medicine, Hiroshima University Graduate School of Biomed
-
Kawano Satoru
Medicine Of Cardiovascular Pathophysiology Graduate School Of Comprehensive Human Science University
-
Higaki Jitsuo
the Department of Geriatric Medicine, Keio University School of Medicine
-
Kaneda Yasufumi
大阪大学 遺伝子治療学
-
KATSUYA Tomohiro
the Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
Morishita Ryuichi
Osaka Univ. Graduate School Of Medicine Suita Jpn
-
KAIBE Masaharu
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
KOMAI Norio
Department of Geriatric Medicine, Osaka University Graduate School of Medicine
-
Noma Takahisa
Second Department of Internal Medicine, Kagawa Medical University
-
Mizushige Katsufumi
Second Department of Internal Medicine, Kagawa Medical University
-
Ohmori Koji
Second Department of Internal Medicine, Kagawa Medical University
-
Nakashima Hideki
Department of Microbiology and Immunologu,Kagoshima University Dental School
-
Shimoda Kazuya
Division Of Cardiovascular Medicine Jichi Medical University School Of Medicine
-
Komai Norio
Department Of Gene Diagnostics And Therapeutics Research Institute International Medical Center Of J
-
荻原 俊男
大阪大学 加齢医学
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Fujio Yasushi
Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sciences Osaka U
-
Fujio Yasushi
Department Of Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sc
-
Nakamura Toshikazu
Department Of Tumor Pathology Gunma University Graduate School Of Medicine
-
Kaneko Yoshihiro
Department Of Internal Medicine Jikei University School Of Medicine
-
Tanabe Tadashi
Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Med
-
Shirato Kunio
Department Of Internal Medicine Ii Sapporo Medical University
-
Sugimura Kohichiro
東北大学 医学系研究科循環器病態学分野
-
Sugimura Koichiro
東北大学 循環器内科
-
Hoshikawa Yoshiko
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
SHIMAMOTO Kazuaki
Committee for Epidemiology and Clinical Management of Atherosclerosis
-
Kizu Takashi
大阪大学 医学系研究科内分泌･代謝内科
-
Iemitsu Motoyuki
筑波大学先端学際領域研究センター
-
Iemitsu Motoyuki
Cardiovascular Division Department Of Internal Medicine Institute Of Clinical Medicine
-
Iemitsu Motoyuki
Center For Tsukuba Advanced Research Alliance (tara) University Of Tsukuba
-
Shirato Kunio
東北大学 第1内科
-
Nagai Ryozo
Department Of Cardiovascular Medicine University Of Tokyo Graduate School Of Medicine
著作論文
- Characteristics of Chronic Rejection in Heart Transplantation : Important Elements of Pathogenesis and Future Treatments
- Does therapeutic angiogenesis overcome CKD?
- Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
- Genetic basis of hypertension for the development of tailored medicine
- OE-071 A Genom-Wide Association Study of SNPs in the risk of Atherosclerosis Obliterans(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- DPJ-013 Hepatocyte Growth Factor Attenuates TGF-β1 Angiotensin II Crosstalk by Down Regulation of Angiotensin II Type 1 Receptor through PTEN/Akt Pathway(DPJ03,Kidney/Renal Circulation/CKD (H),Digital Poster Session (Japanese),The 73rd Annual Scientific M
- Variation in OSBPL10 is associated with dyslipidemia
- Serum hepatocyte growth factor concentration is a specific marker of endothelial dysfunction in humans
- PJ-042 Pivotal Roles of CYLD (cylindromatosis) as a Deubiquitinating Enzyme in Vasculature(Atherosclerosis, basic(05)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Recognition of Tissue- and Subtype-Specific Modulation of Angiotension II Receptors Using Antibodies against AT_1 and AT_2 Receptors
- Anti-Aging Medicine in Cardiovascular Disease
- Symposium on The Etiology of Hypertension - Summerizing Studies in 20th Century -, Hypertension and Genes
- Lack of Association between the Hepatocyte Growth Factor Receptor, c-met, and the Anti-Apoptotic Action of Bag-1 in Endothelial Cells
- Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension
- Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)
- Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site
- Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation
- Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease
- Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites
- Therapeutic Angiogenesis Induced by Endotherial Nitric Oxide Synthase Gene through VEGF Expression in Rat Hindlimb Ischemia Model
- Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration
- PJ-145 Periostin as a Novel Therapeutic Target for Heart Failure(Acute coronary syndrome, basic/clinical-7, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-024 New Mechanisms of an Angiotensin Receptor Blocker, Valsartan, on the Heart Failure through the Inhibition of Novel Anti-adhesion Molecule, Periostin(Heart failure, basic-2 (M) OJ4,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific
- Periostin as a Anti-adhesion Molecule Responsible for Ventricular Dilation(Heart Failure, Basic 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-003 Docking Protein Gab1 is Essential for HGF-dependent Endothelial Signaling and Angiogenesis after Hindlimb Ischemia(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The J
- PE-062 Zyxin Progresses Epithelial-Mesenchymal Transition under the Control of Twist1 and Contributes to Endocardial Morphogenesis(PE011,Congenital Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation S
- The challenge of stopping the knocking down of metabolic dominos upstream
- OE-137 Pivotal Roles of Inflammatory Factors in Arteriosclerosis and its Specific Regulation(Infection/Inflammation/Immunity-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-117 An Initial Result of 2-Year Follow Up of 17 Clinical Cases With an NF-κ B Decoy Transfection at the Coronary Stenting(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis
- PJ-086 Regression of Experimental Rabbit Aortic Aneurysm by The Treatment with Chimera Decoy Oligodeoxynucleotides (ODN) against ets and NFkB(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- OJ-094 Delayed Post-ischemic Treatment with Fluvastatin Improved Learning and Memory Deficit After Stroke in Rats without affecting Infarction Volume(Cerebrovascular circulation / Stroke-1, The 71st Annual Scientific Meeting of the Japanese Circulation So
- PJ-654 Post-ischemic Administration of Fluvastatin Improves Cognitive Dysfunction in the Chronic Stage of Cerebral Infarction in Rat Model(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meet
- PJ-652 Over-expression of HGF Improves Learning and Memory and Prevents Progressive Shrinkage of Thalamus in the Chronic Stage of Cerebral Infarction(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scie
- PJ-740 Hepatocyte Growth Factor (HGF), but not Vascular Endothelial Growth Factor (VEGF), Attenuated Ang II-induced EC Senescence by Inhibiting PIP3/rac1 Activity(PJ124,Peripheral Cirulation/Vascular Disease (Therapy) 4 (H),Poster Session (Japanese),The 7
- OJ-060 Hepatocyte Growth Factor Attenuate Ang II-induced Inflammation and Proliferation of Smooth Muscle Cell through EGF Receptor Degradation(OJ10,Atherosclerosis, Basic (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-686 Hepatocyte Growth Factor Can Attenuate Senescense of EPC through Anti-oxidative Stress Effect(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Application of Decoy Oligodeoxynucleotides for Arthritis
- 3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Hepatocyte Growth Factor(HGF) as a Potential Index of Severity of Hypertension
- IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM
- IS028 GENE THERAPY OF RESTENOSIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) THROUGH THE ACCELATION OF RE-ENDOTHELIALIZATION
- Contribution of a Vascular Modulator, Hepatocyte Growth factor (HGF), to the Pathogenesis of Cardiovascular Disease
- IS053 ANTI-APOPTOTIC ACTION OF HEPATOCYTE GROWTH FACTOR ON HUMAN AORTIC ENDOTHELIAL CELLS
- Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System
- PE-275 A Novel Strategy of the Gene Therapy for PAD Using Small RNA Interference of Cold Shock Domain Protein A(PE046,Atherosclerosis (Basic, Clinical/Diagnosis) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
- 2 Estrogen Decreases the Activation of RANK-RANKL System in Vascular Calcification(Young Investigator's Award for International Students Finalists Lecture (YIA International),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-250 Cold shock domain protein A, novel regulator of angiogenesis in heart.(Coronary circulation, basic/clinical(03)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-185 Topical application of novel angiogenic peptide, AG-30, in wound healing model(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-040 FHL-2 Expresses in Endothelial Cell and Suppresses VEGF-induced Angiogenesis Via Sphingosine Kinase-1(Arrhythmia, diagnosis/Pathophysiology/EPS(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society
- OJ-195 Pivotal Roles of Deubiquitinating Enzymes UCHL1, HAUSP, and CYLD in Vasculature as an Anti-proliferative and Anti-inflammatory Effect(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Adipose Tissue-Derived Stromal Cells as a Novel Option for Regenerative Cell Therapy
- PJ-752 A Novel Model of Vasculogenesis From ES Cells for Vascular Research and Regenerative Medicine(Development and differentiation-4 (M) PJ129,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Gene therapy for ischemic brain disease with special reference to vascular dementia
- PJ-709 Amyloid β 1-40 Disrupts Vascular Regeneration through the Inhibition of Endothelial Akt signaling(Regeneration (angionenesis/myocardial regeneration)-7 (M) PJ119,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
- PJ-477 A Therapeutic Strategy to Treat Brain Ischemia : Over-expression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury in Rat Model(Cerebrovascular Circulation/Stroke 1 (H) : PJ80)(Poster Session (Japanese))
- PJ-345 Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-B Suppression by Anoikis of Myofibroblasts(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
- OJ-125 HGF,but not VEGF, Attenuated Angiotensin II-induced Senescence in EPC through Anti-Oxidative Stress Effect by Inhibiting Rac1 Activation.(Regeneration(angiogenesis / myocardial regeneration)(02)(M),Oral Presentation (Japanese),The 72nd Annual Scien
- PJ-762 Requirement of HIF-1a Signaling on the Expression of Nkx2.5 for Normal Heart Developement in Xenopus(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-188 Angiogenic and Anti-fibrotic Actions of Hepatocyte Growth Factor Improve Cardiac Dysfunction in Porcine Ischemic Cardiomyopathy(Genetics/Genetically engineered models/Gene therapy-3 (M) PJ32,Poster Session (Japanese),The 70th Anniversary Annual Sci
- PJ-098 Ubiquitin C-terminal Hydroxylase L1 (UCHL1), the Causative Genes of Inherited Parkinson's Disease, Has an Anti-inflammatory Action in Endothelial Cells(Molecular biology, vascular-3 (H) PJ17,Poster Session (Japanese),The 70th Anniversary Annual Sci
- PE-114 Angiotensin II Blocker, Valsartan, Supresses the Development of Experimental Abdominal Aortic Aneurysm in Rats(Peripheral circulation/Vascular disease(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
- PJ-691 Inhibition of Development of Experimental Aortic Abdominal Aneurysm in Rat Model by Atorvastatin through Inhibition of Macrophage Migration(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation So
- PE-543 Inhibiton of Experimental Aortic Abdominal Aneurysm by Angiotensin Receptor Blocker, Valsartan(Peripheral circulation/Vascular disease-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Two Years Follow-up of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (Engl
- Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor
- Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin 12 Analogue) in the Porcine Coronary Artery after Angioplasty
- Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF)
- Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease
- Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer)
- Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF
- No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF
- Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer)
- Preliminary clinical results from TREAT-HGF : Gene therapy for PAD
- OJ-213 Prevention of Abdominal Aortic Aneurysm using Ribbon-type Chimeric Decoy Oligodeoxynucleotides against NF κ B and Ets in a Rat Model(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circ
- OJ-028 Role of NF κ B and Ets in Development of Abdominal Aortic Aneurysm in Human(Peripheral circulation/Vascular disease-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 5 Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Clinical Trials of Regeneration Therapy in Japan, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-391 Hypertension Accelerated Experimental Abdominal Aortic Aneurysm through Up-regulation of Transcription Factors, NFkB and Ets(Peripheral circulation-2 (H) OJ66,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
- OJ-338 Long Term Results and Sub-analysis from Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease (PAD)(Genetics/Genetically engineered models/Gene therapy-1 (M) OJ57,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Me
- OJ-337 Regression of Abdominal Aortic Aneurysms by Chimeric Decoy Oligonucleotides against NF κ B and Ets Binding Sites in Rabbit Model(Genetics/Genetically engineered models/Gene therapy-1 (M) OJ57,Oral Presentation (Japanese),The 70th Anniversary Annual
- OJ-029 Suppression of Anastomotic Intimal Hyperplasia in Rabbit Hypercholesterolemic Model using Chimeric Decoy Oligodeoxynucleotides against NF κ B and E2F(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversary Annual Sc
- Improvement of Myocardial Dysfunction by Therapeutic Angiogenesis Induced by Transfection of HGF Gene in Porcine Chronic Myocardial Ischemia Model(Gene Therapy 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Regression of Experimental Rabbit Aortic Aneurysm by the Treatment with Chimeric Decoy Oligodeoxynucleotides (ODN) against Ets and NFkB(Gene Therapy 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Inhibitory Effect of NFκB Decoy Oligodeoxynucleotides (ODN) on the Neointimal Hyperplasia in Rabbit Vein Graft Model(Cardiovascular Surgery/CABG 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-090 Therapeutic angiogenesis by a transcription factor : Ets-1 for peripheral arterial disease(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- OE-328 Increase in DNA Synthesis of Cardiomyocytes by Transfection of Antisense p53 and Rb Oligodeoxynucleotides : Possibility of Regeneration of Cardiomyocytes(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English))
- Overexpression of HGF (Hepatocyte Growth Factor) Reduced Ischemic Injury in Rat Permanent Middle Cerebral Artery Occlusion (MCAO) Model
- Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model
- Acceleration of Neointimal Hyperplasia in Lp (a) Transgenic Mice : Contribution of Lp (a) in the Pathogenesis of Vascular Disease
- Hepatocyte Growth Factor as Cardiovascular Hormone: Role of HGF in the Pathogenesis of Cardiovascular Disease
- Novel High Efficiency Gene transfer Technique into neonatal cardiac myocyte : Second Generation of HVJ vector (HVJ-envelope)
- Gene therapy for preventing delayed neuronal death using hepatocyte growth factor
- Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene
- Acceleration of neointimal hyperplasia in Lp(a) transgenic mice : Contribution of Lp(a) in the pathogenesis of vascular disease
- Novel Molecular Therapeutic Approach to Cardiovascular Disease Based on Hepatocyte Growth Factor (HGF)
- PJ-341 Acceleration of wound healing by combination gene transfer of Hepatocyte Growth Factor and Prostacyclin Synthase with Shima Jet(Peripheral Circulation/Vascular Disease 3(H) : PJ57)(Poster Session (Japanese))
- PJ-751 Role of HIF-1 α on Vascular and Heart Development in Xenopus : HIF-1 α Regulated Cardiac Development Independent of Vascular or Blood Development(Development and differentiation-4 (M) PJ129,Poster Session (Japanese),The 70th Anniversary Annual Scie
- In vivo Gene Transfer for the Therapy of Vascular Diseases
- PE-383 HGF Gene Therapy Ameliorates Secondary Lymphedema through Lymphangiogenesis(Genetics/Genetically engineered models/Gene therapy-2 (M) PE64,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Novel Therapeutic Approach Using siRNA to Reduce Plasama High Concentration of Lp(a)(Lipid Disorders 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Development of a Novel Ribbon-type Decoy Oligonucleotides to Treat Renal Damages Induced by Hypertension and Diabetes(Kidney/Renal Circulation 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Therapeutic Potential of a Novel Ribbon-type Decoy Oligonucleotides for Vascular Diseases(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OE-211 Differentiation of ES cells into sprouting vessels on Matrigel without growth factors(Angiogenesis 1 (M) : OE26)(Oral Presentation (English))
- Vascular Specific Organogenesis from Embryonic Stem Cells on Three Dimensional Layer of Matrigel
- Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells
- Development of Novel High Throughput Functional Screening System Based on HVJ-E Vector : Screening of Anti-vascular Remodeling Factor in Hypertension(Hypertension, Basic 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-278 Important Role of Nuclear Factor-κ(NF κB) in Neointimal Formation in Porcine Balloon Injury Model(Infection/Inflammation/Immunity 3 (H) : PJ47)(Poster Session (Japanese))
- PJ-091 Improvement of Diabetic Neuropathy by HGF Gene Transfer(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- PJ-089 Potential of Novel Ribbon-type E2F Decoy in vivo Neointimal Hyperplasia(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- OJ-529 Ribozyme Oligonucleotides Against TGF-Beta Transferred by Ultrasound Inhibited the Progression of Diseases in Anti-Thy1 Model(Kidney/Renal Circulation 3 (H) : OJ65)(Oral Presentation (Japanese))
- OJ-377 Combination Therapy by ACEI and ARB on vascular remodeling in a porcine coronary artery injury model(Restenosis after Angioplasty, Basic/Clinical 3 (IHD) : OJ46)(Oral Presentation (Japanese))
- Gene Therapy to Treat Diabetic Neuropathy : Improvement of Diabetic Peripheral Neuropathy by HGF Gene and Prostacyclin Synthase Gene Transfer
- Co-Transfection of Human Hepatocyte Growth Factor and Prostacyclin Synthase Gene Enhanced Therapeutic Angiogenesis in Rat and Rabbit Ischemia Model
- Development of Novel Therapeutic Angiogenesis Strategy Using Co-transfection of Human PGIS Gene with HGF as Preclinical Study
- A Novel Autologous Cell Therapy into Ischemic Limb Diseases by Adipose Tissue-derived Stromal Cells through Growth Factor Secretion(Vasoactive Compound/Growth Factor/Cytokine 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor : Potential Gene Therapy for Ischemic diseases
- IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation
- PJ-087 Enhanced Therapeutic Angiogenesis by Co-transfection of Prostacyclin Synthase Gene or Optimization of Intramuscular Injection of Naked Plasmid DMA(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- Development of a novel gene transfer method mediated by ultrasound with microbubbles
- Novel Molecular Therapeutic Approach to Cardiovascular Disease Based on Hepatocyte Growth Factor
- The Role of Hepatocyte Growth Factor (HGF) in Vasculogenesis and Angiogenesis in Xenopus Development
- Hepatocyte growth factor specifies hemotopoitic mesoderm in Xenopus embryos
- Cardiovascular Disease and Angiogenesis
- Functional Analysis of Cardiovascular Renin-Angiotensin System Using a Gain or Loss of Function Approach
- Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel
- How to evaluate real-world medicine in a Japanese population : important lessons from the JIKEI, CASE-J, KYOTO and VART studies
- 5 Role of University-Spin Off Ventures in Academia(Problems to be Resolved in the Cooperative Studies and Development of Medical Products Between Academic and Industrial Worlds, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Functional Analysis of Cis-element and Bindibng Protein as Regulators of Angiotensinogen Generation in SHR
- INHIBITION OF NEOINTIMAL FORMATION AND INCREASED LOCAL VASCULAR HEPATOCYTE GROWTH FACTOR (HGF) PRODUCTION IN BALLOON INJUREDARTERIFSBY ANGIOTENSIN CONVERTING ENZYME INHIBITOR
- Angiogenesis and Its Therapeutic Implication 4. Cardiovascular Disease and Angiogenesis